Vedolizumab for acute gastrointestinal graft-versus-host disease: A systematic review and meta-analysis

Vedolizumab for acute gastrointestinal graft-versus-host disease: A systematic review and meta-analysis

ObjectiveTo determine the safety and efficacy of vedolizumab for the prophylaxis and treatment of gastrointestinal involvement of acute graft-versus-host disease (GVHD) (GI-aGVHD).MethodsLiterature search within PubMed, EMBASE, Web of Science, and Cochrane Library for observational studies and clini...

Full description

Bibliographic Details
Main Authors:	Allen Cheng-Wei Li, Chen Dong, Soon-Tzeh Tay, Ashwin Ananthakrishnan, Kevin Sheng-Kai Ma
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-11-01
Series:	Frontiers in Immunology
Subjects:	vedolizumab graft-versus-host disease biologics alpha-4-beta-7 integrins acute GVHD
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2022.1025350/full

Similar Items

Population pharmacokinetic modeling of vedolizumab for graft‐versus‐host disease prophylaxis in adults with allogeneic hematopoietic stem cell transplant
by: Timothy Waterhouse, et al.
Published: (2024-10-01)

Vedolizumab plus basiliximab as second-line therapy for steroid-refractory lower gastrointestinal acute graft-versus-host disease
by: Zicheng Gao, et al.
Published: (2024-07-01)

HPV32‐related Heck’s disease in a chronic graft‐versus‐host disease patient with long‐term successful KTP laser treatment: A rare case report
by: Joe Truong Nguyen, et al.
Published: (2021-05-01)

Clinical Response to Vedolizumab in Ulcerative Colitis Patients Is Associated with Changes in Integrin Expression Profiles
by: Friederike Fuchs, et al.
Published: (2017-07-01)

Possible Efficacy of Vedolizumab, an Anti-α4β7 Integrin Antibody, in Palmoplantar Pustulosis
by: Hitoshi Terui, et al.
Published: (2023-01-01)

ORAL GRAFT VERSUS HOST DISEASE: A REVIEW
by: Reddy Lavanya, et al.
Published: (2016-03-01)

Local immune cell infiltration in cutaneous acute graft versus host disease
by: Rachel Sennett, MD, PhD, et al.
Published: (2020-09-01)

Diagnostic and prognostic role of elafin in skin acute graft versus host disease: a systematic review
by: Abhinav Bhattarai, et al.
Published: (2024-12-01)

Graft versus host disease occurring in living donor liver transplant
by: Nalini Bansal, et al.
Published: (2018-01-01)

Hyperacute graft-versus-host disease of the skin following allogeneic stem cell transplantation: A paediatric case series
by: Gauri D Mahabal, et al.
Published: (2023-01-01)

Elephantiasis nostra verrucosa in sclerodermatous chronic graft-versus-host disease
by: Jamila Mammadova, MD, MA, et al.
Published: (2025-03-01)

A brief account on ocular graft versus host disease
by: Debapriya Chatterjee
Published: (2023-01-01)

Effects of Anti-Integrin Treatment With Vedolizumab on Immune Pathways and Cytokines in Inflammatory Bowel Diseases
by: Timo Rath, et al.
Published: (2018-07-01)

Vedolizumab as a Potential Culprit in the Development of Ovarian Teratoma?
by: Judy A. Trieu, et al.
Published: (2017-12-01)

A product review of vedolizumab in inflammatory bowel disease
by: Robert Battat, et al.
Published: (2019-10-01)

Janus kinase inhibition in the treatment and prevention of graft-versus-host disease
by: Elisa De Togni, et al.
Published: (2024-02-01)

PD-L1’s Role in Preventing Alloreactive T Cell Responses Following Hematopoietic and Organ Transplant
by: Shane Handelsman, et al.
Published: (2023-06-01)

Dry eye disease and risk factors for corneal complications in chronic ocular graft-versus-host disease
by: Anahita Kate, et al.
Published: (2023-01-01)

Vedolizumab: toward a personalized therapy paradigm for people with ulcerative colitis
by: Dart RJ, et al.
Published: (2017-03-01)

Genital GVHD in Female Children and Adolescents: A Systematic Review of Case Reports and Case Series
by: Maria Tsimeki, et al.
Published: (2023-08-01)

Safety of autologous freshly expanded mesenchymal stromal cells for the treatment of graft-versus-host disease
by: Elizabeth Stenger, et al.
Published: (2022-09-01)

Longitudinal relationship between the gut microbiota variation and diversity and gut graft-versus-host disease (GVHD) following pediatric allogeneic hematopoietic cell transplantation (HCT) – Case series
by: Ashley N. Gray, et al.
Published: (2023-05-01)

Acute Chest Pain as an Infusion Reaction to Vedolizumab
by: Asaf Levartovsky, et al.
Published: (2022-06-01)

Chronic Ocular GVHD Treatment at Two Locations of a Tertiary Referral Center
by: Qureshi MB, et al.
Published: (2024-09-01)

Vedolizumab in Inflammatory Bowel Disease: West versus East
by: Prasanta Debnath, et al.
Published: (2021-01-01)

Comparison of the Effectiveness of Vedolizumab and Ustekinumab in Patients with Ulcerative Colitis: A Real-World Retrospective Study
by: Kei Nomura, et al.
Published: (2024-09-01)

A real-world study of vedolizumab versus infliximab in patients with moderate to severe ulcerative colitis
by: MENG Ruiping, et al.
Published: (2024-06-01)

Vedolizumab in the treatment of inflammatory bowel diseases: whom and how?
by: A. O. Golovenko, et al.
Published: (2018-10-01)

Crohn’s Disease with Atypical Extra-Intestinal Manifestations Developing Under Treatment with Vedolizumab
by: Aasem Abu Shtaya, et al.
Published: (2021-02-01)

Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease Using Commercial Mesenchymal Stem Cell Products
by: Makoto Murata, et al.
Published: (2021-08-01)

Selective biologics for ulcerative colitis and Crohn's disease – clinical utility of vedolizumab
by: Petkau JM, et al.
Published: (2016-03-01)

Post Transplantation Bilirubin Nanoparticles Ameliorate Murine Graft Versus Host Disease via a Reduction of Systemic and Local Inflammation
by: Sumedha Pareek, et al.
Published: (2022-06-01)

Real-World Study on Vedolizumab Serum Concentration, Efficacy, and Safety after the Transition from Intravenous to Subcutaneous Vedolizumab in Inflammatory Bowel Disease Patients: Single-Center Experience
by: Vlasta Oršić Frič, et al.
Published: (2023-02-01)

The Experience of Ibrutinib in Chronic Graft-Versus-Host Disease in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: Single Center Experience
by: Ahmet Sarıcı, et al.
Published: (2023-05-01)

The effectiveness and safety of vedolizumab induction for moderate to severe ulcerative colitis for Asia patient: A real practice observational study
by: Chia-Jung Kuo, et al.
Published: (2022-09-01)

Challenges and concepts in the diagnosis and management of ocular graft-versus-host disease
by: Christoph Tappeiner, et al.
Published: (2023-02-01)

Refractory Chronic Pouchitis and Autoimmune Hemolytic Anemia Successfully Treated with Vedolizumab
by: Diana Martins, et al.
Published: (2018-02-01)

Efficacy and safety of vedolizumab in Crohn’s disease in patients from Asian countries in the GEMINI 2 study
by: Rupa Banerjee, et al.
Published: (2021-01-01)

Advances in extracorporeal photopheresis
by: Zhanrui CHENG, et al.
Published: (2022-07-01)

Old and New Biologics and Small Molecules in Inflammatory Bowel Disease: Anti Integrins
by: Kyeong Ok Kim, et al.
Published: (2024-08-01)